Markets›Health care›DHR

Danaher

DHR
224.49
+0.72 (+0.32%)
Closing price for Sep 25, 2026 from Polygon.io
Income statement Balance sheet Cash flow | Annual Quarterly |Download CSV
Income statement (USD) FY 2025
ended Dec 31, 2025
FY 2024
ended Dec 31, 2024
FY 2023
ended Dec 31, 2023
FY 2022
ended Dec 31, 2022
FY 2021
ended Dec 31, 2021
FY 2020
ended Dec 31, 2020
Revenue 24.57B23.88B23.89B26.64B24.80B22.28B
Cost of revenue 10.04B9.67B9.86B10.46B9.56B9.81B
Gross profit 14.52B14.21B14.03B16.19B15.24B12.47B
Research and development 1.60B1.58B1.50B1.53B1.50B1.35B
Selling, general and admin 8.23B7.76B7.33B7.12B6.82B6.90B
Operating income 4.69B4.86B5.20B7.54B6.38B4.23B
EBITDA 5.44B5.58B7.37B9.67B8.44B6.01B
Interest expense 265.00M278.00M286.00M204.00M231.00M275.00M
Income before tax 4.23B4.65B5.04B7.15B6.51B4.50B
Income tax 633.00M747.00M823.00M818.00M1.06B849.00M
Net income 3.61B3.90B4.76B7.21B6.43B3.65B
EPS 5.075.336.449.808.774.97
EPS (diluted) 5.055.296.389.668.614.89
Diluted shares 716.10M737.20M743.10M737.10M736.80M718.70M

From Danaher's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read income statement or reading a 10-K.

Charts

Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.